US 10570393
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted A61KA61K31/713A61K47/549
Quick answer
US patent 10570393 (Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K31/713, A61K47/549, A61P, A61P3/06